AbbVie Inc. (FRA:4AB)
Germany · Delayed Price · Currency is EUR 178.80
+1.40 (0.79%)
Last updated: Sep 9, 2025, 5:28 PM CET
AbbVie Revenue
AbbVie had revenue of $15.42B USD in the quarter ending June 30, 2025, with 6.65% growth. This brings the company's revenue in the last twelve months to $58.33B, up 6.05% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$58.33B
Revenue Growth
+6.05%
P/S Ratio
6.39
Revenue / Employee
$1.06M
Employees
55,000
Market Cap
317.19B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
| Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
| Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
| Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
| Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.89B |
| Siemens Aktiengesellschaft | 78.30B |
| Deutsche Telekom AG | 120.55B |
| Allianz SE | 109.02B |
| Rheinmetall AG | 10.67B |
| Siemens Energy AG | 38.39B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
| Deutsche Bank Aktiengesellschaft | 30.07B |
AbbVie News
- 19 hours ago - AbbVie Inc. (ABBV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 22 hours ago - AbbVie Inc (ABBV) Launches "The One & Only" Campaign for BOTOX® Cosmetic | ABBV ... - GuruFocus
- 1 day ago - BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories - PRNewsWire
- 1 day ago - Glenmark Pharma shares jump over 2% after its subsidiary gets $700 million from AbbVie for licensing deal - Business Upturn
- 1 day ago - Glenmark Pharma receives $700 million upfront payment from AbbVie for global licensing deal - Business Upturn
- 1 day ago - Calls of the Day: Abbvie, Vertex, Veeva and Vistra - CNBC
- 2 days ago - 1 Reason Every Investor Should Know About AbbVie (ABBV) - The Motley Fool
- 4 days ago - AbbVie Inc (ABBV) Declares Quarterly Cash Dividend | ABBV stock news - GuruFocus